Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Tidswell

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Intensive Care Medicine|November 11, 2005
Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomesThomas L Higgins, Jay S Steingrub, Gary J Tereso, et al.
Critical Care Explorations|August 28, 2025
Organ Failure, Endotoxin Activity, and Mortality in Septic ShockLuca Molinari, Mark A Tidswell, Ali Al-Khafaji, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
High-flow nasal cannula vs non-invasive ventilation in acute hypoxia: Propensity score matched studyElizabeth S Munroe, Ina Prevalska, Madison Hyer, et al.
Critical Care Explorations|May 10, 2024
High-Flow Nasal Cannula Versus Noninvasive Ventilation as Initial Treatment in Acute Hypoxia: A Propensity Score-Matched StudyElizabeth S Munroe, Ina Prevalska, Madison Hyer, et al.
Journal of Hospital Medicine|November 24, 2020
Safety Assessment of a Noninvasive Respiratory Protocol for Adults With COVID-19William E Soares, Elizabeth M Schoenfeld, Paul Visintainer, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trialJavier A Neyra, Matthieu Legrand, Mark A Tidswell, et al.
CHEST Critical Care|January 23, 2026
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER TrialD Clark Files, Michael A Matthay, Lorraine B Ware, et al.
The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Intensive Care Medicine|November 11, 2005
Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomesThomas L Higgins, Jay S Steingrub, Gary J Tereso, et al.
Critical Care Explorations|August 28, 2025
Organ Failure, Endotoxin Activity, and Mortality in Septic ShockLuca Molinari, Mark A Tidswell, Ali Al-Khafaji, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
High-flow nasal cannula vs non-invasive ventilation in acute hypoxia: Propensity score matched studyElizabeth S Munroe, Ina Prevalska, Madison Hyer, et al.
Critical Care Explorations|May 10, 2024
High-Flow Nasal Cannula Versus Noninvasive Ventilation as Initial Treatment in Acute Hypoxia: A Propensity Score-Matched StudyElizabeth S Munroe, Ina Prevalska, Madison Hyer, et al.
Journal of Hospital Medicine|November 24, 2020
Safety Assessment of a Noninvasive Respiratory Protocol for Adults With COVID-19William E Soares, Elizabeth M Schoenfeld, Paul Visintainer, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trialJavier A Neyra, Matthieu Legrand, Mark A Tidswell, et al.
CHEST Critical Care|January 23, 2026
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER TrialD Clark Files, Michael A Matthay, Lorraine B Ware, et al.
The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
Pageof 2